
Communications Associate Vice President @cityofhope Opinions are my own.
Los Angeles
Joined June 2008
- Tweets1.2K
- Following675
- Followers430
- Likes673
Come on, let's vote for this innovative first in human CAR T trial! This is all for fun, friendly competition and Baylor is currently beating us with a mouse study :) For this round, you can vote 5 times! #STATMadness2025
@TDorffOnc
@SaulPriceman
@elizabeth_budde
@montypal
#STATMadness continues!
Our @cityofhope team (feat. @TDorffOnc's research titled "CAR-T therapy for prostate cancer") has advanced to round 2 of the bracket-style competition and we need your votes!
Up to 5 votes per person allowed: bit.ly/4iixQft #STATMadness2025
59
Chantal Roshetar retweeted
In this @NPR feature, learn about a groundbreaking treatment giving hope to patients like DeShawn Chow, a 19-year-old battling sickle cell disease at City of Hope Children's Cancer Center. n.pr/4dajeLP
So happy to be back in person for this inspiring event
What an incredible day! On May 3, over 4,000 blood cancer survivors gathered to celebrate our 48th annual BMT reunion. Thank you to everyone who joined us to make this day so special. Read more: bit.ly/3QZjyFh
1
99
A convergence of glioblastoma CAR T publications including @CityofHope, Harvard and Penn: cnn.com/2024/03/13/health/ca…
58
Illumina chief commercial officer leaves to lead liquid biopsy startup Delfi statnews.com/2024/01/04/illu… via @statnews
1
1
73
What a great #ASH23 so far!
City of Hope will be at #ASH23! Our doctors and scientists will deliver their latest research, including a late-breaking abstract presented by Ibrahim Aldoss, M.D., on Monday, December 11.
Learn more: CityofHope.org/ash23
2
167
Chantal Roshetar retweeted
The FDA has approved the world’s first medicine based on #CRISPR gene-editing technology, a groundbreaking treatment for sickle cell disease. 🧵 trib.al/GvM8dux
Such an honor to work closely with Dr. Carpten and thank you to Paul Goldberg @cancerletter for capturing some of his vision for @cityofhope
.@cityofhope's John Carpten: "In America, opportunities have not been provided or made available equitably. That history can’t simply be forgotten...I've always come from the standpoint that there’s no reason to separate excellence from diversity.”
cancerletter.com/conversatio…
1
134
Chuck E. Cheese is getting rid of its animatronic bands, except here…it’s not our beloved neighborhood locale ktla.com/news/local-news/chu…
46
Well deserved and honored to work with this amazing leader
John D. Carpten, Ph.D., chief scientific officer, the Irell & Manella Cancer Center Director's Distinguished Chair and Morgan & Helen Chu Director's Chair of the Beckman Research Institute has been elected to @theNAMedicine. Read: cityofhope.org/john-d-carpte… #NAMmtg
82
A Third-Generation French Baker Opens LA’s Newest Croissant Contender in Pasadena la.eater.com/2023/6/22/23743… via @EaterLA
1
67
Chantal Roshetar retweeted
Anyone paying attention in medicine has been hearing a lot about obesity drugs. Same for Alzheimer's.
Here's a question: how is it that one company, Eli Lilly, ended up being in pole position in both diseases?
I went digging and found a buddy movie.
statnews.com/2023/07/06/eli-…
Chantal Roshetar retweeted
June is National Cancer Survivor Month, and I need your help! I am looking to feature videos from cancer survivors! Send a 10-15 second video sharing words of hope for those still in the fight! Please email these videos to: [email protected]
Subject: Cancer Survivor video
🫶🏼 – at Los Angeles, CA
Chantal Roshetar retweeted
Flawless presentation by @DrChoueiri at #ASCO23 of #CONTACT03 results. We didn’t sleep much over the past several weeks putting this manuscript together for simultaneous pub in @TheLancet! Thank you to @katy_beckermann & @brian_rini for a terrific editorial accompanying the piece. Clearly, we need prospective data (across tumor types!) before we re-challenge w IO. Thank you to @NehaVapiwala & the @ASCO committee for highlighting our work!
1/ Results from #CONTACT03 are out both @ASCO #ASCO23 and @TheLancet . The 1⃣st phase 3 trial to assess the efficacy of rechallenge with anti-PDL1 in ANY cancer type.
Kudos to @montypal, SC members, @roche, our patients, = for this phenomenal job.
thelancet.com/journals/lance…
One of our most exciting pieces of data this year...plenary, press briefing #ASCO23
Alex Herrera, M.D., discusses the results from a @SWOG Phase 3 study that compared nivolumab-AVD and brentuximab vedotin-AVD in patients with Stage 3 or 4 classic Hodgkin lymphoma. #ASCO23
Alex Herrera, M.D., Discusses Results of SWOG S1826 Study
2
115
Chantal Roshetar retweeted
City of Hope is proud to join #CancerX as a founding member to unleash the power of innovation in the fight against #cancer as part of the #CancerMoonshot initiative. More: cityofhope.org/city-hope-joi…

ALT Graphic: Quote: There is a gap between the cancer innovation taking place and the people who can actually access these breakthroughs. City of Hope is committed to working to close that gap by finding solutions and innovations that help make leading-edge research, treatment and care accessible to more patients and communities. End Quote. HARLAN LEVINE, M.D. President of Health Innovation and Policy
Aww that smile! Congrats to our very own giant...Dr. Forman
Congratulations are in order for Stephen J. Forman, MD, of @cityofhope for being awarded as a 2023 Giant of Cancer Care® in Leukemia! #leusm #GiantsCC23
Thank you @CBSLAKristine for reporting on this story and especially your passion to help people!
With stage 4 cancer and months left to live, Rokhsan Enonoria fought her insurance company for a life-prolonging surgery. They denied the request and City of Hope stepped in to gift the surgery -- adding years to her life. cbsnews.com/losangeles/news/…
51


















